“Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis” (2025) Open Access Indonesian Journal of Medical Reviews, 6(1), pp. 1–20. doi:10.37275/oaijmr.v6i1.819.